In a rare but significant complication of cancer, the body's immune system can begin attacking the brain, resulting in rapid-onset memory loss and cognitive impairment. What precipitated this unexpected biological civil war was mostly unknown.
According to a study published in Cell Reports Medicine in January, researchers at Tisch Cancer Institute showed that a certain form of chemotherapy boosts the immune system's ability to fight bladder cancer, especially when paired with immunotherapy.
A recent study published in the Journal of Clinical Immunology has provided light on the particular alterations causing a rare and fatal ailment called 'RAD50 deficiency/Nijmegen breakage syndrome-like disorder'.
New Delhi [India], November 17: To celebrate the inauguration of its first image enabled high-speed spectral flow cytometry sorting facility in South Asia, BD Life Sciences-Biosciences, a segment of BD (Becton Dickinson and Company) in association with Indian Institute of Technology Jodhpur
Researchers have shed light on the specific variations responsible for an uncommon and deadly condition known as 'RAD50 deficiency/Nijmegen breakage syndrome-like disorder' in a study published recently in the Journal of Clinical Immunology.
In a paper published in The Journal of Allergy and Clinical Immunology that describes analyses led by Corinne Keet, MD, PhD, pediatric allergy and immunology professor in the UNC Department of Pediatrics of two longitudinal studies, the authors show that the people who produced IgE antibodie
A group led by scientists at The University of Texas at Austin has discovered a brand-new, bio-inspired medication that restores the capability of immune cells to combat cancer. The medication increases the effectiveness of immunotherapy and inhibits tumour growth in mice models of melanoma,
For decades, scientists have understood that pregnancy requires a mother's body to modify so that her immune system does not fight the developing foetus as if it were a hostile foreign invader.
Despite knowing a lot more about pregnancy immunology in recent years, a new study demonstrates t
The researchers shed light on the immune cells' capacity to collectively migrate through diverse environments in their work, which was published today in Science Immunology.
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.
Thanks to a new study led by scientists at the La Jolla Institute for Immunology (LJI) and the Medical College of Georgia (MCG) at Augusta University, scientists can finally track down a dangerous type of human T cell.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.